| Roche Pharma (Schweiz) AG - Hemlibra 300mg/2ml, Injektionslösung |
| 66694 | | 06 | | Hemlibra 300mg/2ml | | Injektionslösung | | B02BX06 | | Emicizumab | | 04.11.2024 | | |
|
| Composition |
| emicizumabum 300 mg, histidinum, acidum asparticum, argininum, poloxamerum 188, aqua ad iniectabile ad solutionem pro 2 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Emicizumabum | 300mg / 2ml |
| | BAG: Active Agent | Dose |
|---|
| Emicizumabum | 300 mg |
| | | | Inactive agents | Dose |
|---|
| Aspartic Acid | | | Arginine | | | Histidine | | | Poloxamer | 188 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | | 18537.40 | 19060.40 | A | SL | No |
|
